⌘K
Loading ticker…
As of 2026-08-24, Bicara Therapeutics Inc. Common Stock (BCAX) has a 3-month relative strength percentile of 65 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 63. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 6.4%, relative volume 0.99×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
BCAX is held by 22 ETFs as of May 2026. Top owner: VTWO at 0.02% weight, $4M notional. Top 3 carry $9M.
Held by 46 ETFs · $96M across latest filings · largest weight 0.88% (SBIO).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTWO | 0.02% | $4M | — |
| SCHASchwab U.S. Small-Cap ETF | 0.01% | $3M | — |
| VHTVanguard Health Care ETF | 0.01% | $2M | — |
| SBIO | 0.88% | $1M | +0.28 pp |
| AVSC | 0.04% | $1M | +0.02 pp |
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.03% |
| $562K |
| — |
| SCHBSchwab U.S. Broad Market ETF | 0.00% | $534K | — |
| VTWV | 0.04% | $507K | — |
| ONEQ | 0.00% | $501K | — |
| AVUSAvantis U.S. Equity ETF | 0.00% | $276K | — |
Showing 10 of 22 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | BCAX Jan avg: -13.87% median: -13.87% win: 0% σ: 19.36% n: 2 2024-09-16 → 2026-07-31 | BCAX Feb avg: 2.63% median: 2.63% win: 50% σ: 3.89% n: 2 2024-09-16 → 2026-07-31 | BCAX Mar avg: 8.25% median: 8.25% win: 50% σ: 14.54% n: 2 2024-09-16 → 2026-07-31 | BCAX Apr avg: 9.39% median: 9.39% win: 100% σ: 1.26% n: 2 2024-09-16 → 2026-07-31 | BCAX May avg: -17.42% median: -17.42% win: 50% σ: 25.75% n: 2 2024-09-16 → 2026-07-31 | BCAX Jun avg: 18.47% median: 18.47% win: 100% σ: 25.51% n: 2 2024-09-16 → 2026-07-31 | BCAX Jul avg: 5.43% median: 5.43% win: 50% σ: 20.02% n: 2 2024-09-16 → 2026-07-31 | BCAX Aug avg: 7.47% median: 7.47% win: 100% σ: 0.00% n: 1 2024-09-16 → 2026-07-31 (current) | BCAX Sep avg: 20.52% median: 20.52% win: 100% σ: 16.58% n: 2 2024-09-16 → 2026-07-31 | BCAX Oct avg: -2.06% median: -2.06% win: 50% σ: 7.03% n: 2 2024-09-16 → 2026-07-31 | BCAX Nov avg: 1.00% median: 1.00% win: 50% σ: 18.68% n: 2 2024-09-16 → 2026-07-31 | BCAX Dec avg: -12.77% median: -12.77% win: 0% σ: 4.87% n: 2 2024-09-16 → 2026-07-31 |